Back to Search
MOHAMMAD JAHANZEB MD
MD
Medical Oncology Physician
NPI: 1114919503Individual
Specialties, Licenses & Credentials
Hematology & Oncology Physician
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
36771(TN)17856(MS)E3595(AR)
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
ME68929(FL)
Research & Publications (20)
Phase II trial of weekly vinorelbine and trastuzumab as first-line therapy in patients with HER2(+) metastatic breast cancer.
PMID 12401903·Oncologist·2002
3-trial
Breast cancer. Clinical practice guidelines in oncology.
PMID 19200416·J Natl Compr Canc Netw·2009
6-review
Extensive-stage small-cell lung cancer: evolution of systemic therapy and future directions.
PMID 18953759·Clin Lung Cancer·2008
6-review
Evolution of bevacizumab-based therapy in the management of breast cancer.
PMID 18952553·Clin Breast Cancer·2008
6-review
Venous thromboembolic disease. NCCN. Clinical practice guidelines in oncology.
PMID 18926086·J Natl Compr Canc Netw·2008
6-review
Adjuvant trastuzumab therapy for HER2-positive breast cancer.
PMID 18757259·Clin Breast Cancer·2008
6-review
NCCN Task Force Report: breast cancer in the older woman.
PMID 18597715·J Natl Compr Canc Netw·2008
6-review
Novel taxane formulations in the treatment of breast cancer: a thought leader discussion and consensus roundtable.
PMID 18501057·Clin Breast Cancer·2008
6-review
Phase II study of neoadjuvant docetaxel, vinorelbine, and trastuzumab followed by surgery and adjuvant doxorubicin plus cyclophosphamide in women with human epidermal growth factor receptor 2-overexpressing locally advanced breast cancer.
PMID 17296975·J Clin Oncol·2007
8-other
American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer.
PMID 17968019·J Clin Oncol·2007
1-meta
Oral versus intravenous administration of vinorelbine as a single agent for the first-line treatment of metastatic nonsmall cell lung carcinoma (NSCLC): A randomized phase II trial.
PMID 17551300·Am J Clin Oncol·2007
3-trial
Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women.
PMID 17919537·Clin Ther·2007
6-review
Venous thromboembolic disease. Clinical practice guidelines in oncology.
PMID 17020664·J Natl Compr Canc Netw·2006
6-review
HER2 testing in breast cancer: NCCN Task Force report and recommendations.
PMID 16813731·J Natl Compr Canc Netw·2006
6-review
Non-small cell lung cancer clinical practice guidelines in oncology.
PMID 16813724·J Natl Compr Canc Netw·2006
6-review
Phase II study of neoadjuvant docetaxel/ vinorelbine followed by surgery and adjuvant doxorubicin/cyclophosphamide in women with stage II/III breast cancer.
PMID 16595034·Clin Breast Cancer·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 2155 W MAYA PALM DR
BOCA RATON, FL 33432 - Phone
- (910) 483-0486
Quick Facts
- NPI
- 1114919503
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 4
- Locations
- 3
- Publications
- 20
Are you this provider?
Claim Your Profile